Schedule at a Glance*

Wednesday, October 17



10:00 am – 5:00 pm

On-Site Registration

1:00 pm  4:00 pm
1:00 pm  3:00 pm
3:30 pm – 5:00 pm

Pre-Conference Workshop 1
Pre-Conference Workshop 2
Pre-Conference Workshop 3

Boarding 6:00 pm
Sail 7:00 pm  9:00 pm

Welcome Reception
(Savannah Riverboat Dinner Cruise)

Thursday, October 18



7:00 am – 5:00 pm

On-Site Registration

7:30 am – 8:30 am

Buffet Breakfast Served

8:00 am – 9:00 am

Breakfast Plenary
(See "Detailed Conference Schedule" Below for More Information)

9:15 am – 10:30 am

Breakout Session 1
(See "Detailed Conference Schedule" Below for More Information)

10:30 am – 10:45 am

Break (snacks and beverages)

10:45 am – 12:00 pm

Breakout Session 2
(See "Detailed Conference Schedule" Below for More Information)

12:00 pm – 1:00 pm

Buffet Lunch Served

12:30 pm – 1:45 pm

Lunch Plenary
(See "Detailed Conference Schedule" Below for More Information)

2:00 pm – 3:15 pm

Breakout Session 3
(See "Detailed Conference Schedule" Below for More Information)

3:15 pm – 3:30 pm


3:30 pm – 4:45 pm

Breakout Session 4
(See "Detailed Conference Schedule" Below for More Information)

5:00 pm – 6:30 pm

Poster Session
(Cash Bar and Appetizer)


Friday, October 19



7:00 am – 12:00 pm

On-Site Registration / Information

7:30 am – 8:30 am

Buffet Breakfast Served

8:00 am – 9:15 am

Breakfast Plenary
(See "Detailed Conference Schedule" Below for More Information)

9:30 am – 10:45 am

Breakout Session 5
(See "Detailed Conference Schedule" Below for More Information)

10:45 am – 11:00 am

Break (snacks and beverages)

11:00 am – 12:15 pm

Plenary and Closing Remarks
(See "Detailed Conference Schedule" Below for More Information)

Detailed Conference Schedule*

Wednesday, 10/17 

1:00 to 4:00 Pre-conference Workshop 1: Expanding the Impact of Substance use Disorder Research: Economic Analysis for Program and Policy Evaluation  
1:00 to 3:00  Pre-conference Workshop 2: Opportunities and Challenges in Using Claims/Encounter Data in Addiction Health Services Research
3:30 to 5:00   Pre-conference Workshop 3: In the Room Where It Happens:  A Look Inside the NIH Grant Review Process    
6:00 to 9:00   Welcome Reception on Riverboat      

Thursday, 10/18

8:00 to 9:00  Opening Remarks
Breakfast Plenary – Lori Ducharme from NIAAA and Carlos Banco from NIDA

9:15 to 10:30  Session 1 Presentation 1 Presentation 2 Presentation 3 Presentation 4 Presentation 5
  Breakout 1 Innovative Approaches in Payment for SUD Treatment Clinician incentives for program-level performance in substance use disorder treatment Initial Outcomes of Opioid Use Disorder Medicaid Clients Enrolled in New York State's Health Homes Program Accountable Care Organization Participation among Hospitals Offering Substance Use Disorder and Mental Health Services in 2016 Pay for Outcomes: How Might It Work in Substance Use Disorder Treatment? NONE
  Breakout 2 Making a Difference with SUD Performance Measures: Lessons Learned and Future Directions SUD Performance Measures: How Can Two Decades of Experience Inform the Future? Addressing the Challenges in Addiction Quality Improvement: What is the Path Forward? Electronic Health Records: Opportunities and Challenges in Quality Performance Assessment Patient-Reported Outcomes: Changing Who Defines Quality and How it is Measured NONE
  Breakout 3 Implementation Research in Addiction Health Services The effectiveness of Implementation & Sustainment Facilitation: Results from a 39-site cluster randomized trial Implementing a Mobile Health System to Integrate the Treatment of Addiction into Primary Care Organizational Characteristics and Practices That Facilitate Opioid Use Disorder Pharmacotherapy Treatment Implementation NIATx Stages of Implementation Completion: Assessing Provider Engagement Leader Perceptions of Factors Impacting the Successful Implementation of Motivational Interviewing in Substance Use Disorder Treatment programs
  Breakout 4 Impact of health policy on treatment services delivery Effects of the Affordable Care Act on Smoking Cessation Treatment among People with Mental Illness Changes in Payment for MAT Services used by Racial-Ethnic Minority Groups after the ACA Medicaid expansion and substance use treatment utilization Racial/ethnic differences in access to behavioral health treatment before and after implementation of the 2008 federal parity law Differential effects of state naloxone laws, ACA expansion status, and payer source on the rate of naloxone dispensing: Per state per month estimation between 2011 and 2017
  AM Break
10:45 to 12:00  Session 2 Presentation 1 Presentation 2 Presentation 3 Presentation 4 Presentation 5
  Breakout 5 Integrating Care for Substance Use Disorders and HIV/AIDS The effectiveness of a motivational interviewing-based brief intervention for substance use within community-based AIDS service organizations: Results from a multisite randomized controlled trial Processes for implementing electronic substance use, depression and anxiety screening and behavioral interventions in HIV primary care settings Substance Use Screening to Improve Integrated Care of Substance Use Disorders in HIV Clinic Settings Need for Training and Support for Naloxone Prescription and OBOT among HIV Providers NONE
  Breakout 6 Implementation of integrated care; challenges and triumphs Implementing Integrated Services Into Routine Care for Persons With Co-Occurring Disorders Implementing Buprenorphine Treatment: Conjoint Analyses of Dose and Office Visit
Adjustments Based on Patient Progress
Addressing the Opioid Epidemic through Integrated Care Usability testing of a mHealth prototype to enhance linkage and retention in HIV, HCV, and buprenorphine treatment in primary care  NONE
  Breakout 7 Improving the Effectiveness and Implementation of SBIRT in Healthcare Settings Universal substance use screening and brief intervention: A hierarchical analysis of effects on healthcare utilization and treatment services Clinical Recognition of Substance Use Disorders in Primary Care as a result of universal Screening, Brief Intervention and Referral to Treatment (SBIRT) Faculty development efforts to promote screening, brief intervention, and referral to treatment (SBIRT) using EHR Tools and Performance Feedback Screening, Brief Intervention, and Referral to Treatment (SBIRT): Implementation Characteristics and Implications for Sustainability Cost and cost-effectiveness of electronic- and clinician-delivered SBIRT for women in reproductive healthcare centers
  Breakout 8 Primary Care Integration of Routine Substance Use Screening: Care Implementation, Clinical Characteristics and Outcomes of Patients Screened for Alcohol, Cannabis, and Illicit drug use Evaluation of a Pilot Implementation Study to Integrate Care Related to Cannabis and Illicit Drug Use into Primary Care Prevalence of Behavioral Health Conditions across Frequency of Cannabis Use Among Adult Patients in 3 Primary Care Clinics in Washington State Frequency of cannabis use among pregnant women in a large health care system in Washington state Routine Primary Care Screening for Cannabis and Other Drug Use and Risk of Subsequent Acute Care Utilization in an Integrated Health System Routine Primary Care Screening for Unhealthy Alcohol Use and Risk of Subsequent Acute Care Utilization in an Integrated Health System
12:30 to 1:45  Lunch Plenary – Lisa Marsch from Dartmouth University
2:00 to 3:15  Session 3   Presentation 1 Presentation 2 Presentation 3 Presentation 4 Presentation 5
  Breakout 9 Opioid use disorder pharmacotherapy: Assessing implementation and measuring quality Pharmacotherapy for Opioid Use Disorder – Performance Measures in Commercial Health Insurance and Medicaid Trends and Disparities in Opioid Agonist Therapy Among Medicaid-Enrollees Opioid use disorder ambulatory care and medication use among the commercially insured Addressing research gaps in the quality of opioid use disorder treatment Buprenorphine treatment for Opioid Use Disorders within the Veterans Health Administration
  Breakout 10 Morbidity and mortality and the opioid epidemic Using Machine Learning to Predict Risk of Opioid Overdose in Fee-for-Service Medicare Evaluating State Pill Mill Laws' Effects on Opioid Overdose Deaths The evolving opioid crisis in racial/ethnic minority communities in the U.S. Dual Receipt of Prescription Opioids from Both VA and Medicare Part D is Associated with Prescription Opioid Overdose Deaths NONE
  Breakout 11 System Design to Better Treat Opioid Addiction Statewide Implementation of the Massachusetts Nurse Care Manager Model of Office-Based Addiction Treatment for Individuals with Opioid Use Disorder Hub and Spoke Model to Improve Pharmacotherapy Use for Opioid Addiction – Early Implementation How is Telemedicine Being Used for Opioid and Other Substance Use Disorders? A New Care Model: Creating a Collaborative Pharmacy Practice Agreement Model for Medications for Addiction Treatment in Community Pharmacies Access to Office-Based Opioid Treatment in a Rural Epidemic: Provider Shortages in Counties With High Overdose Burden
  Breakout 12 Community based responses to the opioid crisis Expanding Low-Threshold Buprenorphine to Justice-Involved individuals through a Mobile Treatment Van: Addressing a Critical Gap in Baltimore City Safe Station: Characterizing Consumers of a Novel Community-based Model to Tackle the Opioid Crisis Implementation and Enforcement of Laws Targeting High-Risk Opioid Prescribing Practices The Role of Police Officers in Delivering Health Services Related to Opioid Misuse in Lexington, Kentucky  NONE
  PM Break
3:30 to 4:45  Session 4 Presentation 1 Presentation 2 Presentation 3 Presentation 4 Presentation 5
  Breakout 13 Enhancing Substance Use Treatment Needs and Service Delivery for Justice Involved Youth: Findings from JJ-TRIALS A Structured Implementation Intervention to Improve Substance Use Services for Justice-involved Youth: Preliminary Findings from a Multisite Cluster Randomized Trial Unpacking system effects of an implementation intervention using site developed quality improvement plans Community Supervision Agency Practices for Engaging Caregivers in Behavioral Health Services: Findings from a National Survey Service Receipt as a Mediator of Treatment Needs and Recidivism NONE
  Breakout 14 Pregnant Women with Opioid Use Disorder: Barriers and Facilitators to Best Practices Framework for Considering Treatment for Pregnant Women with Opioid Use Disorders (OUDs) and their infants Healthcare utilization and chronic conditions in the first 3 years of life among children born to women with opioid use disorder in pregnancy Creating a Community of Mothers with Mental Illness Using Opioids Facilitating Best Practice in the Perinatal Care of Women with Opioid Use Disorders Overcoming Community and Policy Barriers to Treatment for Pregnant Women Addicted to Opioids in Rural North Georgia
  Breakout 15 Identifying and Treating Opioid Use in Adolescents Buprenorphine Treatment for Adolescents and Young Adults with Opioid Use Disorders: The State of the Science Extended Release Naltrexone for Opioid-Dependent Youth: Three-month Outcomes Receipt of Recommended Pharmacotherapy for Opioid Use Disorder and Retention in Care Among Youth: A Multistate Study Opioid outcomes among justice involved youth: Can integrating data from multiple service systems help identify youth at risk for overdose and other adverse events? NONE
  Breakout 16 Substance use prevention and treatment services for adolescents Utilization of Health Care Services among Adolescents following Pediatrician and Behavioral Clinician-Delivered Screening, Brief Intervention and Referral to Treatment Distilling the Core Elements of Family Therapy for Adolescent Substance Use via Observational Fidelity Analyses Cost Effectiveness of Extended-Release Naltrexone for Opioid Dependent Youth SBIRT for adolescents in primary care: Sustainability of services following cessation of implementation supports Performance of Substance Use Frequency as a Brief Screen for Adolescent Substance Use Problems Among Different Racial/Ethnic Groups
5:00 to 6:30   Poster Session 

Friday, 10/19 

08:00 to 09:15 Breakfast Plenary – Rosalie Pacula from RAND and a second presenter TBA
09:30 to 10:45    Session 5 Presentation 1 Presentation 2 Presentation 3 Presentation 4 Presentation 5
  Breakout 17 Addressing substance use disorders in disadvantaged populations Prevalence of OUD diagnosis and medication treatment among Medicaid-enrolled pregnant women in 3 states Trends in opioid use disorder treatment for pregnant women in Medicaid, 2009-2015 Comparing Coverage in Exchange and Medicaid Plans for People with Behavioral Health Disorders Health Home Program for HIV-Positive Medicaid Clients in New York State: Preliminary Outcomes Age Cohort Patterns of Medication-Assisted Treatment Use among New York Medicaid Members Newly Diagnosed with Opioid Use Disorder in 2015
  Breakout 18 The Affordable Care Act and Addiction Treatment: Findings from the National Drug Abuse Treatment System Survey Addiction Treatment Benefits in Medicaid Managed Care Plans Comprehensive Service Delivery in Outpatient Addiction Programs from 2000 to 2017 Changes in Technical Assistance Priorities and Allocation of SAPT Block Grant Funds Medicaid Expansion and Availability of Opioid Use Disorder Medications State Medicaid Waiver Innovation in Addiction Treatment
  Breakout 19 Innovative Methods in AHSR to Examine Disparities, Implementation Impact and Adaptive Interventions Accounting for Need for Treatment, Socioeconomic Status, and Discrimination when Measuring Racial/Ethnic Disparities in Substance Use Disorder Treatment Identifying an optimal sequence of individually tailored, level-of-care placement decisions for adolescent substance use: An observational study Disparities in substance use behaviors and disorders among adult sexual minorities by age, gender, and sexual identity Disparities in criminal justice outcome after beginning treatment for SUDs: The influence of race and place NONE
  Breakout 20 Understanding the rural opioid syndemic in the U.S.: Mixed methods approaches and preliminary findings from a multi-site study The Opioid Epidemic in Rural Northern New England: An Epidemiologic, Policy, and Legal Scan Mapping the Policy Environment for Addressing Drug-Related Harms in Appalachian Kentucky Understanding the Opioid Epidemic in Rural Appalachian Ohio: Stakeholder Perspectives Respondent Driven Sampling among Rural PWID in Wisconsin: Early Experience from a Multi-site Study Utilization of Spatial Methods to Address the Rural Opioid Syndemic in Illinois and Oregon

11:00 to 12:15   Plenary – Presenter TBA
                            Closing Remarks



*subject to change